Harvey Brian Nicholas 4

What Happened
Harvey Brian Nicholas, Chief Financial Officer of Adicet Bio, had 546 shares withheld by the company on January 24, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs). The withholding was executed at $8.44 per share, for a total value of $4,608. This withholding is a tax settlement (transaction code F) and, per the filing footnote, does not represent a sale by the reporting person.

Key Details

• Transaction date and price: 2026-01-24 at $8.44 per share.
• Shares withheld: 546 shares; total value $4,608.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes: F1 — shares withheld to satisfy tax withholding on RSU vesting (not a sale). F2 — filing reflects a 1-for-16 reverse stock split effected Dec 30, 2025.
• Filing date: Form 4 filed Jan 27, 2026 (covers the Jan 24, 2026 event). No late-filing flag provided in the summary data.

Context
Share withholding to cover taxes on vested equity is a routine administrative action and typically does not signal an executive choosing to sell shares on the open market. The reported share count has been adjusted for the company’s 1-for-16 reverse split on Dec 30, 2025, per the filing footnote.